Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Matrix initiates phase II trial of IntraDose in primary liver cancer

June 23, 1997

Agouron's IND for anticancer agent approved

June 20, 1997

Sugen receives notices of allowance covering SU-101 for solid tumor treatment

June 19, 1997

NeoPharm begins phase I/II trial for liposome-encapsulated doxorubicin

June 18, 1997

Results from phase II trial with thalidomide for prostate cancer reported

June 18, 1997

Suntory prepares compounds for thrombocytopenia

June 17, 1997

Merck & Co. prepares improved inhibitors of protein farnesyltransferase

June 17, 1997

U.S. notice of patent allowance for troponin I

June 16, 1997

Banyu to shift development from NB-506 to new indolocarbazole

June 13, 1997

Paracelsian cancels launch of AndroCar

June 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.